 |
|
NIH scientists target future pandemic strains of H5N1 avian influenza
August 10, 2007Preparing vaccines and therapeutics that target a future mutant strain of H5N1 influenza virus sounds like science fiction, but it may be possible, according to a team of scientists at the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), and a collaborator at Emory University School of Medicine. Success hinges on anticipating and predicting the crucial mutations that would help the virus spread easily from person to person.
Led by Gary Nabel, M.D., Ph.D., director of the NIAID's Dale and Betty Bumpers Vaccine Research Center (VRC), the team is reporting in the August 10, 2007 issue of the journal Science that they have developed a strategy to generate vaccines and therapeutic antibodies that could target predicted H5N1 mutants before these viruses evolve naturally. This advance was made possible by creating mutations in the region of the H5N1 hemagglutinin (HA) protein that directs the virus to bird or human cells and eliciting antibodies to it.
"What Dr. Nabel and his colleagues have discovered will help to prepare for a future threat," says NIH Director Elias A. Zerhouni, M.D. "While nobody knows if and when H5N1 will jump from birds to humans, they have come up with a way to anticipate how that jump might occur and ways to respond to it."
"Now we can begin, preemptively, to consider the design of potential new vaccines and therapeutic antibodies to treat people who may someday be infected with future emerging avian influenza virus mutants," says NIAID Director Anthony S. Fauci, M.D. "This research could possibly help to contain a pandemic early on."
Making a vaccine against an existing strain of H5N1 or any other type of influenza virus is relatively routine. Typically, samples of existing influenza virus strains are isolated and then grown inside eggs or in cell cultures. The virus is then collected, inactivated, purified and added to the other components of the vaccine.
A flu shot prompts a person's immune system to detect pieces of the inactivated virus present in the vaccine and make neutralizing antibodies against them. Later, if that same person is naturally exposed to a flu virus, these same antibodies should help fight the infection.
Influenza viruses constantly mutate, however, and vaccines are most effective against the highly specific strains that they are made from. This makes it difficult to predict how effective a vaccine made today will be against a virus that emerges tomorrow.
Dr. Nabel and his colleagues started their project by focusing narrowly on mutations that render H5N1 viruses better able to recognize and enter human cells. Bird-adapted H5N1 binds bird cell surface receptors. But these receptors differ slightly from the receptors on human cells, which in part explains why bird-adapted H5N1 can infect but not spread easily between humans.
About a year ago, the research team began asking what mutations help the virus shift its adaptability. They compared the structural proteins on the surface of bird-adapted H5N1 influenza virus with those on the surface of the human-adapted strain that caused the 1918 pandemic. They focused specifically on genetic changes to one portion of the H5 protein--a portion called the receptor binding domain. They showed that as few as two mutations to this receptor binding domain could enhance the ability of H5N1 to recognize human cells.
Additional mutations would likely need to accumulate for H5N1 to spread more easily from person to person, says Dr. Nabel. The few mutations he and his colleagues identified are likely just a subset of those, he emphasizes.
Moreover, they found that these mutations change how the immune system recognizes the virus. Mouse antibodies that target H5N1 were up to tenfold less potent against the mutants. Dr. Nabel and his colleagues used their knowledge of receptor specificity to create vaccines and isolate new antibodies that might be used therapeutically against human-adapted mutants.
They vaccinated mice with the material from viruses they altered to contain the mutant receptors, and they discovered one broadly reactive antibody that could neutralize both the bird- and human-adapted forms of an H5N1 virus.
According to Dr. Nabel, their findings should contribute to better surveillance of naturally occurring avian flu outbreaks by making it easier to recognize dangerous mutants and identify vaccine candidates that might provide greater efficacy against such a virus before it emerges.
"Our findings build on elegant studies of the influenza HA protein by structural biologists," notes Dr. Nabel. "Insight into the structure of the avian flu virus has enabled us to target a critical region of HA that directs its specificity. Such a structure-based vaccine design may allow us to respond to this future threat in advance of an actual outbreak."
NIH/National Institute of Allergy and Infectious Diseases
"Now we can begin, preemptively, to consider the design of potential new vaccines and therapeutic antibodies to treat people who may someday be infected with future emerging avian influenza virus mutants," says NIAID Director Anthony S. Fauci, M.D. "This research could possibly help to contain a pandemic early on."
Making a vaccine against an existing strain of H5N1 or any other type of influenza virus is relatively routine. Typically, samples of existing influenza virus strains are isolated and then grown inside eggs or in cell cultures. The virus is then collected, inactivated, purified and added to the other components of the vaccine.
A flu shot prompts a person's immune system to detect pieces of the inactivated virus present in the vaccine and make neutralizing antibodies against them. Later, if that same person is naturally exposed to a flu virus, these same antibodies should help fight the infection.
Influenza viruses constantly mutate, however, and vaccines are most effective against the highly specific strains that they are made from. This makes it difficult to predict how effective a vaccine made today will be against a virus that emerges tomorrow.
Dr. Nabel and his colleagues started their project by focusing narrowly on mutations that render H5N1 viruses better able to recognize and enter human cells. Bird-adapted H5N1 binds bird cell surface receptors. But these receptors differ slightly from the receptors on human cells, which in part explains why bird-adapted H5N1 can infect but not spread easily between humans.
About a year ago, the research team began asking what mutations help the virus shift its adaptability. They compared the structural proteins on the surface of bird-adapted H5N1 influenza virus with those on the surface of the human-adapted strain that caused the 1918 pandemic. They focused specifically on genetic changes to one portion of the H5 protein--a portion called the receptor binding domain. They showed that as few as two mutations to this receptor binding domain could enhance the ability of H5N1 to recognize human cells.
Additional mutations would likely need to accumulate for H5N1 to spread more easily from person to person, says Dr. Nabel. The few mutations he and his colleagues identified are likely just a subset of those, he emphasizes.
Moreover, they found that these mutations change how the immune system recognizes the virus. Mouse antibodies that target H5N1 were up to tenfold less potent against the mutants. Dr. Nabel and his colleagues used their knowledge of receptor specificity to create vaccines and isolate new antibodies that might be used therapeutically against human-adapted mutants.
They vaccinated mice with the material from viruses they altered to contain the mutant receptors, and they discovered one broadly reactive antibody that could neutralize both the bird- and human-adapted forms of an H5N1 virus.
According to Dr. Nabel, their findings should contribute to better surveillance of naturally occurring avian flu outbreaks by making it easier to recognize dangerous mutants and identify vaccine candidates that might provide greater efficacy against such a virus before it emerges.
"Our findings build on elegant studies of the influenza HA protein by structural biologists," notes Dr. Nabel. "Insight into the structure of the avian flu virus has enabled us to target a critical region of HA that directs its specificity. Such a structure-based vaccine design may allow us to respond to this future threat in advance of an actual outbreak."
NIH/National Institute of Allergy and Infectious Diseases
Avian Influenza Current Events and Avian Influenza News RSSStopping germs from ganging up on humans
Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson.
Protein 'tubules' free avian flu virus from immune recognition
A protein found in the virulent avian influenza virus strain called H5N1 forms tiny tubules in which it "hides" the pieces of double-stranded RNA formed during viral infection, which otherwise would prompt an antiviral immune response from infected cells, said Baylor College of Medicine researchers in an online report in the journal Nature.
Avian flu threat: New approach needed
As the first globally co-ordinated plan for the planet's gravest health threats is hatched by government ministers from around the world this weekend, a new report sets out a 10-point plan for this new, globalised approach to infectious diseases such as avian flu.
'Deadly dozen' reports diseases worsened by climate change
Health experts from the Wildlife Conservation Society today released a report that lists 12 pathogens that could spread into new regions as a result of climate change, with potential impacts to both human and wildlife health and global economies.
Scientists working to protect NI from Bird Flu
Queen's scientists are involved in two international projects aimed to protect Northern Ireland's agri-food industry from Bird Flu and African Swine Fever, a disease which kills pigs.
Discovery opens door for drugs to fight bird flu, other influenza epidemics
Researchers at Rutgers University and The University of Texas at Austin have reported a discovery that could help scientists develop drugs to fight the much-feared bird flu and other virulent strains of influenza.
The pandemic potential of H9N2 avian influenza viruses
Since their introduction into land-based birds in 1988, H9N2 avian influenza A viruses have caused multiple human infections and become endemic in domestic poultry in Eurasia.
Booster vaccination may help with possible future avian influenza pandemic
New evidence suggests that a booster vaccination against H5N1 avian influenza given years after initial vaccination with a different strain may prove useful in controlling a potential future pandemic. The study is published in the August 1 issue of The Journal of Infectious Diseases, now available online.
Newly described 'dragon' protein could be key to bird flu cure
Scientists and researchers have taken a big step closer to a cure for the most common strain of avian influenza, or "bird flu," the potential pandemic that has claimed more than 200 lives and infected nearly 400 people in 14 countries since it was identified in 2003.
Battling bird flu by the numbers
A pair of Los Alamos National Laboratory researchers have developed a mathematical tool that could help health experts and crisis managers determine in real time whether an emerging infectious disease such as avian influenza H5N1 is poised to spread globally.
More Avian Influenza Current Events and Avian Influenza News Articles
 | Avian Influenza Avian Influenza provides the first comprehensive guide covering the full spectrum of this complex and increasingly high-profile disease, its history and its treatment and control. All aspects of avian influenza are dealt with in depth, systematically covering biology, virology, diagnostics, ecology, epidemiology, clinical medicine, and the control. The book fuses coverage of the latest... |
 | Avian Influenza Virus (Methods in Molecular Biology) With the growing global fear of a major pandemic, avian influenza virus research has increased greatly in importance during this young century. In Avian Influenza Virus, an expert team of researchers and diagnosticians examine the fundamental yet essential virological methods for AI virus research and diagnostics as well as some of the newest molecular procedures currently used for basic and... |
 | Avian Influenza (Monographs in Virology) Because of its high impact on both animal and human health, avian influenza has become a matter of increasing public concern and growing scientific interest within the last decade. This volume gives an overview of the most important results of these research efforts and provides information about the ecology and epidemiology of avian influenza with particular emphasis on recent H5N1 outbreaks in... |
| Discrimination between highly pathogenic and low pathogenic H5 avian influenza a viruses.(Letter to the editor) : An article from: Emerging Infectious Diseases by Sunchai Payungporn, Salin Chutinimitkul, Arunee Chaisingh, Sudarat Damrongwantanapokin, Bandit Nuansrichay, Wasana Pinyochon, Alongkorn Amonsin, Ruben O. Donis, Apiradee Theamboonlers, Yong Poovorawan This digital document is an article from Emerging Infectious Diseases, published by Thomson Gale on April 1, 2006. The length of the article is 1304 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle:... | |
 | Making Preparation Count: Lessons from the Avian Influenza Outbreak in Turkey (Euro Publication) by World Health Organization. Regional Office for Europe This booklet describes the outbreak of human cases of avian influenza in Turkey and the national and international response. Drawing on interviews with some of the key health workers and major agencies involved - the European Centre for Disease Prevention and Control (ECDC), the United Nations Children's Fund (UNICEF), the Food and Agriculture Organization of the United Nations (FAO) and the... |
 | The Bird Flu Handbook: What Is Avian Influenza, And What Do We Need To Know To Be Prepared For A Pandemic? by Manoj Kunda Written in a convenient, concise, and easy to read format, The Bird Flu Handbook is an excellent resource guide that provides extremely valuable and up to date information concerning one of the most serious issues in the global news today!Avian Influenza, or Bird Flu, and the impending threat of a worldwide pandemic that could cost millions of lives and cripple the global economy. The Bird Flu... |
 | Influenza: Human And Avian in Practice (In Practice Series) by Roy Jennings, Robert C Read In the modern era where rapid and relatively easy global travel is commonplace, the spread of infectious diseases, particularly influenza, represents a very real and almost annual threat to communities worldwide. Current extensive and global interest in influenza lies in the increasingly common reports of the transmission of a number of avian influenza virus strains to humans. Due to the high... |
 | The Monster at Our Door: The Global Threat of Avian Flu by Mike Davis A “brilliant” and “fascinating” investigation of the looming avian flu pandemic—and how we arrived at the brink of a global health catastrophe—The New York TimesThe virus known as H5N1 is now endemic among poultry and wild bird populations in East Asia. A flu strain of astonishing lethality, it has a talent for transforming itself to foil the human immune system—and kills two out of... |
| Evolution of H5N1 avian influenza viruses in Asia.(highly pathogenic ): An article from: Emerging Infectious Diseases This digital document is an article from Emerging Infectious Diseases, published by Thomson Gale on October 1, 2005. The length of the article is 5606 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation... | |
| Vaccination: A Tool for the Control of Avian Influenza (Developments in Biologicals) |
| © 2008 BrightSurf.com |